The Republic of Iraq, with its rich agricultural heritage along the Tigris and Euphrates, is undergoing a profound transformation in its livestock and poultry sectors. As a leading vaccine products supplier in Iraq, we understand that the country's food security depends heavily on the health of its animal populations. The veterinary market in Iraq is not just a commercial sector; it is a critical pillar of national stability and economic reconstruction.
Iraq's poultry industry has seen a resurgence in regions like Erbil, Baghdad, and Basra. Following years of infrastructure challenges, the Iraqi Ministry of Agriculture has prioritized local production to reduce reliance on imports. However, the high density of poultry farms in provinces like Babil and Sulaymaniyah makes them vulnerable to infectious diseases. Newcastle Disease (ND), Avian Influenza (AI), and Infectious Bursal Disease (IBD) remain significant threats to smallholders and commercial giants alike.
Supplying vaccines in Iraq presents unique logistical hurdles. The primary challenge is the "Cold Chain" integrity. With summer temperatures frequently exceeding 50°C (122°F), maintaining a consistent temperature of 2°C to 8°C during transit from Basra port or Baghdad International Airport to remote farms in the Nineveh plains is crucial. Our technology-driven approach utilizes IoT monitoring to ensure that every vial of Newcastle Disease or H5 Avian Influenza vaccine arrives with its potency fully intact.
The trend in Iraq is moving towards "Precision Veterinary Medicine." Large-scale poultry integrators in the Kurdistan region are now adopting AI-driven monitoring systems to detect early signs of respiratory distress in flocks. This technological shift creates a demand for high-efficiency vaccines that can be administered via automated systems. Our Automatic Vet Syringe Poultry Continuous Chicken Vaccine Guns are becoming the standard tool for modern Iraqi veterinarians who demand speed and accuracy.
In Iraq, the H9N2 subtype of Avian Influenza has become endemic in several regions, causing significant economic losses through reduced egg production and secondary bacterial infections. Our Bird Ndv La Sota Strain Aiv H9 Subtype Ss Strain Killed Vaccine is specifically formulated to provide cross-protection against circulating local strains. For the Iraqi climate, killed vaccines (inactivated) are often preferred for their stability, while live vaccines are used for rapid mucosal immunity in the early stages of a bird's life.
The Iraqi government's "Agricultural Investment Vision" aims to make the country self-sufficient in white meat and eggs by 2030. This will require a 300% increase in veterinary pharmaceutical availability. As a primary vaccine products supplier, we are expanding our local partnerships in Karbala and Najaf to provide not just products, but comprehensive technical training for local veterinary technicians.
Hangzhou Jeci Biochem Technology Co., Ltd. is located in Hangzhou, Zhejiang Province. We are committed to sales of active pharmaceutical ingredients, pharmaceutical intermediates, nutritional products and food additives, cooperative R & D, custom manufacturing, sales and service as well as import of these kinds of materials.
In China, we have a strong collaborative R&D team, working in depth with new drug research institutes and multiple custom processing plants. We have very good domestic sales channels and have long-term relationships with domestic companies, including product applications, technology transfer, product supply, custom processing, and exclusive agents for multiple products in multiple regions. In addition, we also provide factory quality management system certification consulting services.
Internationally, we have long-term trade relations with India, Southeast Asia, South Korea, Japan and other markets, and provides products in the whole process of market and sales services. At the same time, we also provide product registration, consulting and sales channel expansion services for overseas companies in the Chinese market.
Drugs and intermediates are widely used in the following aspects (partial):
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization.
For the company's main product intermediates: We can maximize our advantages, meet the requirements of most customers and complete the task within the specified time limit.
SJ medical
